MICHELE PIERCE: Open Payments
NPI 1255668968 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 32 payments from 12 companies in 2025. Trend: 2023 $58 · 2024 $531 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $154 |
| Gilead Sciences, Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| ABBVIE INC. | 3 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Ardelyx, Inc. | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $47 |
| VIVUS LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Novo Nordisk Inc | 1 | $22 |
Products named: REZDIFFRA, DUPIXENT, VOQUEZNA, IBSRELA, TREMFYA, ENTYVIO, RINVOQ, SKYRIZI.
Industry payments across CT — which companies pay providers there.
